Index > Vol. 85/2005 > Iss. 1/January > pp. 2-8 > Abstract
Letter to the Editor

HLA-Cw*0602 Associates More Strongly to Psoriasis in the Swedish Population than Variants of the Novel 6p21.3 Gene PSORS1C3

doi: 10.1080/00015550410023527

Abstract:

The PSORS1 locus in the major histocompatibility complex region on chromosome 6p21.3 contains a major predisposing factor for psoriasis for which several candidate genes have been tested. The analyses are complicated by strong linkage disequilibrium in the region and the complex genetic background of psoriasis. In the search for an alternative to HLA-C we have identified a novel gene, PSORS1C3, and characterized it with regard to psoriasis. PSORS1C3 is located approximately 7 kb centromeric to POU5F1. A putative protein of 58 amino acids was predicted and expression was detected in both normal and psoriasis skin. Sequencing of the coding region revealed a total of 11 single nucleotide polymorphisms. When comparing the frequencies of PSORS1C3 variants in a case-control material in the Swedish population, three single nucleotide polymorphisms displayed significant association with psoriasis. This association appeared to be HLA-Cw*0602-dependent due to linkage disequilibrium, thus HLA-C remains the strongest associating factor in the region.

Key words:

multifactorial, genetic predisposition, linkage disequilibrium, major histocompatibility complex, single nucleotide polymorphisms

References:

  1. Hellgren L The prevalence in sex, age and occupational groups in total populations in Sweden. Morphology, inheritance and association with other skin and rheumatic diseases. Psoriasis. 1967; Stockholm Almqvist & Wiksell
  2. Christophers E, Mrowietz U The inflammatory infiltrate in psoriasis. Clin Dermatol 1995; 13: 131-135
  3. Lomholt G Psoriasis. Prevalence, spontaneous course, and genetics: a census study on the prevalence of skin diseases on the Faroe Islands. 1963; Copenhagen GEC Gad
  4. Christophers E, Kiene P Guttate and plaque psoriasis. Dermatol Clin 1995; 13: 751-756
  5. Martinez-Borra J, Gonzalez S, Santos-Juanes J, Sanchez del Rio J, Torre-Alonso J. C, Lopez-Vazquez A, et al Psoriasis vulgaris and psoriatic arthritis share a 100 kb susceptibility region telomeric to HLA-C. Rheumatology (Oxford) 2003; 42: 1089-1092
  6. Henseler T, Christophers E Psoriasis of early and late onset: characterization of two types of psoriasis vulgaris. J Am Acad Dermatol 1985; 13: 450-456
  7. Elder J. T, Nair R. P, Henseler T, Jenisch S, Stuart P, Chia N, et al The genetics of psoriasis 2001: the odyssey continues. Arch Dermatol 2001; 137: 1447-1454
  8. Dean M Approaches to identify genes for complex human diseases: lessons from Mendelian disorders. Hum Mutat 2003; 22: 261-274
  9. Jenisch S, Westphal E, Nair R. P, Stuart P, Voorhees J. J, Christophers E, et al Linkage disequilibrium analysis of familial psoriasis: identification of multiple disease-associated MHC haplotypes. Tissue Antigens 1999; 53: 135-146
  10. Nair R. P, Stuart P, Henseler T, Jenisch S, Chia N. V, Westphal E, et al Localization of psoriasis-susceptibility locus psors1 to a 60-kb interval telomeric to hla-c. Am J Hum Genet 2000; 66: 1833-1844
  11. Veal C. D, Capon F, Allen M. H, Heath E. K, Evans J. C, Jones A, et al Family-based analysis using a dense single-nucleotide polymorphism-based map defines genetic variation at PSORS1, the major psoriasis-susceptibility locus. Am J Hum Genet 2002; 71: 3
  12. Gudjonsson J. E, Karason A, Antonsdottir A, Runarsdottir E. H, Hauksson V. B, Upmanyu R, et al Psoriasis patients who are homozygous for the HLA-Cw*0602 allele have a 2.5-fold increased risk of developing psoriasis compared with Cw6 heterozygotes. Br J Dermatol 2003; 148: 233-235
  13. Sanchez F, Holm S. J, Mallbris L, O'Brien K. P, Ståhle-Bäckdahl M STG does not associate with psoriasis in the Swedish population. Exp Dermatol 2004; 13: 413-418
  14. Enerbäck C, Nilsson S, Enlund F, Inerot A, Samuelsson L, Wahlström J, et al Stronger association with HLA-Cw6 than with corneodesmosin (S-gene) polymorphisms in Swedish psoriasis patients. Arch Dermatol Res 2000; 292: 525-530
  15. Chang Y. T, Tsai S. F, Lin M. W, Liu H. N, Lee D. D, Shiao Y. M, et al SPR1 gene near HLA-C is unlikely to be a psoriasis susceptibility gene. Exp Dermatol 2003; 12: 307-314
  16. Holm S. J, Carlén L. M, Mallbris L, Ståhle-Bäckdahl M, O'Brien K. P Polymorphisms in the SEEK1 and SPR1 genes on 6p21.3 associate with psoriasis in the Swedish population. Exp Dermatol 2003; 12: 435-444
  17. Asumalahti K, Veal C, Laitinen T, Suomela S, Allen M, Elomaa O, et al Coding haplotype analysis supports HCR as the putative susceptibility gene for psoriasis at the MHC PSORS1 locus. Hum Mol Genet 2002; 11: 589-597
  18. O'Brien K. P, Holm S. J, Nilsson S, Carlén L, Rosenmüller T, Enerbäck C, et al The HCR gene on 6p21 is unlikely to be a psoriasis susceptibility gene. J Invest Dermatol 2001; 116: 750-754
  19. Teraoka Y, Naruse T. K, Oka A, Matsuzawa Y, Shiina T, Iizuka M, et al Genetic polymorphisms in the cell growth regulated gene, SC1 telomeric of the HLA-C gene and lack of association of psoriasis vulgaris. Tissue Antigens 2000; 55: 206-211
  20. Gonzalez S, Martinez-Borra J, Del Rio J. S, Santos-Juanes J, Lopez-Vazquez A, Blanco-Gelaz M, et al The OTF3 gene polymorphism confers susceptibility to psoriasis independent of the association of HLA-Cw*0602. J Invest Dermatol 2000; 115: 824-828
  21. Staden R The Staden package. 1994; pp. 9-170In: Griffin A. M, Griffin H. G, eds. Methods in molecular biology Totawa
  22. Sonnhammer E. L, Durbin R A dot-matrix program with dynamic threshold control suited for genomic DNA and protein sequence analysis. Gene 1995; 167: GC1-10
  23. Sambrook J, Fritsch R. F, Maniatis T Molecular cloning: a laboratory manual. 1989; New York Cold Spring Harbour Laboratory Press
  24. Bunce M, O'Neill C. M, Barnardo M. C, Krausa P, Browning M. J, Morris P. J, et al Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995; 46: 355-367
  25. Elston R, Olson J, Palmer L Biostatistical genetics and genetic epidemiology, 1st edn. 2002
  26. Breslow N. E, Day N. E The analysis of case-control studies. Statistical methods in cancer research, Vol. 1. 1980; Lyon International Agency for Research on Cancer
  27. Li S. S, Khalid N, Carlson C, Zhao L. P Estimating haplotype frequencies and standard errors for multiple single nucleotide polymorphisms. Biostatistics 2003; 4: 513-522
  28. Lander E. S, Linton L. M, Birren B, Nusbaum C, Zody M. C, Baldwin J, et al Initial sequencing and analysis of the human genome. Nature 2001; 409: 860-921
  29. Zanetti M Cathelicidins, multifunctional peptides of the innate immunity. J Leukoc Biol 2004; 75: 39-48
  30. Eddy S. R Non-coding RNA genes and the modern RNA world. Nat Rev Genet 2001; 2: 919-929
  31. Hirotsune S, Yoshida N, Chen A, Garrett L, Sugiyama F, Takahashi S, et al An expressed pseudogene regulates the messenger-RNA stability of its homologous coding gene. Nature 2003; 423: 91-96
  32. Mattick J. S Challenging the dogma: the hidden layer of non-protein-coding RNAs in complex organisms. Bioessays 2003; 25: 930-939
  33. Trembath R. C, Clough R. L, Rosbotham J. L, Jones A. B, Camp R. D, Frodsham A, et al Identification of a major susceptibility locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997; 6: 813-820
  34. Nickoloff B. J, Schroder J. M, von den Driesch P, Raychaudhuri S. P, Farber E. M, Boehncke W. H, et al Is psoriasis a T-cell disease? Exp Dermatol 2000; 9: 359-375